The FDA has approved Sandoz's Tyruko, a biosimilar to Biogen's (BIIB) blockbuster Tysabri, making it the first biosimilar for MS to be approved.
https://seekingalpha.com/news/4006231-fda-approves-sandoz-biosimilar-of-biogen-blockbuster-ms-drug-tysabri
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.